Author

Elizaveta Rabushko

Institution: Sechenov University

Observed institutions: Moscow Institute of Physics and Technology, Sechenov University, Lomonosov Moscow State University

OpenAlex ID: A5065724525

Clinically relevant fusion oncogenes: detection and practical implications

2022 · Maksim Sorokin, Elizaveta Rabushko, et al. · Therapeutic Advances in Medical Oncology · 37

Experimentally Deduced Criteria for Detection of Clinically Relevant Fusion 3′ Oncogenes from FFPE Bulk RNA Sequencing Data

2022 · Elizaveta Rabushko, Maxim Sorokin, et al. · Biomedicines · 16

RNA Sequencing Data for FFPE Tumor Blocks Can Be Used for Robust Estimation of Tumor Mutation Burden in Individual Biosamples

2021 · Maxim Sorokin, Alexander Gorelyshev, et al. · Frontiers in Oncology · 16

Experimental and Meta-Analytic Validation of RNA Sequencing Signatures for Predicting Status of Microsatellite Instability

2021 · Maksim Sorokin, Elizaveta Rabushko, et al. · Frontiers in Molecular Biosciences · 14

RNA Sequencing for Personalized Treatment of Metastatic Leiomyosarcoma: Case Report

2021 · Alexander Seryakov, Zaynab Magomedova, et al. · Frontiers in Oncology · 9

A New Approach of Detecting ALK Fusion Oncogenes by RNA Sequencing Exon Coverage Analysis

2024 · Galina Zakharova, Maria Suntsova, et al. · Cancers · 3

Insertional activity of human Alu and L1 retrotransposons is associated with DNA repair pathways and genome instability in cancer

2026 · Maria Suntsova, Alexander Modestov, et al. · Computers in Biology and Medicine · 1

Works count: 7

Citation count: 96

H-index: 5

I10-index: 4